Anti-Human PSEN2 Monoclonal Antibody (1A529)
A cutting-edge biotech product designed to target and inhibit the activity of PSEN2, a key protein involved in Alzheimer’s disease.
This highly specific antibody is derived from a unique monoclonal cell line and has been extensively validated for its specificity and potency. It is a valuable tool for researchers studying the role of PSEN2 in neurodegenerative diseases and for drug discovery efforts targeting this protein.
The biological function of PSEN2 is crucial in the progression of Alzheimer’s disease, as it plays a key role in the production of amyloid beta plaques, a hallmark of the disease. By targeting and blocking the activity of PSEN2, this antibody can help to reduce the formation of these plaques and potentially slow down the progression of Alzheimer’s disease.
The Anti-Human PSEN2 Monoclonal Antibody (1A529) has a wide range of applications in both basic research and drug development. It can be used in various techniques such as Western blotting, immunohistochemistry, and immunofluorescence to detect and quantify PSEN2 levels in different sample types, including tissue lysates and cell cultures.
Furthermore, this antibody has been shown to be effective in experimental models of Alzheimer’s disease, making it a valuable tool for in vivo studies. Its high specificity ensures reliable and reproducible results, making it an ideal choice for researchers looking to validate their findings and advance their understanding of PSEN2’s role in Alzheimer’s disease.
In addition to its use in Alzheimer’s disease research, the Anti-Human PSEN2 Monoclonal Antibody (1A529) has also shown potential in other neurodegenerative diseases, such as Parkinson’s disease and frontotemporal dementia. Its versatility and specificity make it a valuable asset for researchers investigating the role of PSEN2 in various neurological disorders.
In summary, the Anti-Human PSEN2 Monoclonal Antibody (1A529) is a highly specific and potent tool for studying the role of PSEN2 in neurodegenerative diseases. Its wide range of applications and proven effectiveness in experimental models make it an essential asset for researchers in the field. Order now and take a step closer to unlocking the mysteries of Alzheimer’s disease and other neurodegenerative disorders.
There are no reviews yet.